Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial

Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    New update timestamps were added (2026-07-06, 2026-07-02, 2026-06-29) and older timestamps removed (2026-07-01, 2026-06-30, 2026-05-26). These entries reflect administrative updates to the study record rather than substantive changes.
    Difference
    0.2%
    Check dated 2026-07-12T20:59:29.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Updated the study contact information by replacing Nirali N Shah, M.D. with Sara K Silbert, M.D., including new phone and email details. The page's revision tag was updated from v3.6.2 to v3.6.3.
    Difference
    0.3%
    Check dated 2026-07-05T14:37:56.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now shows a new revision number, v3.6.2, replacing the previous v3.6.0. This indicates an internal update to the page rendering without changing the study information displayed.
    Difference
    0.0%
    Check dated 2026-06-28T08:53:43.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page now includes new user-focused sections and links such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study, with recent revision markers (2026-06-10 and 2026-06-09) and a v3.6.0 update. Older sections like Intervention / Treatment and NCI Pediatric Leukemia, Lymphoma Transpl were removed, indicating a reorganization of participation and treatment details.
    Difference
    0.5%
    Check dated 2026-06-14T05:11:48.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A new revision label v3.5.5 was added to the page, indicating a minor platform update rather than substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-07T02:08:51.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The study title and description were updated to reflect a new, more detailed Phase I/II CD19/CD22-CAR T cell trial in children and young adults with B cell malignancies. The update adds phase-specific design elements, dosing cohorts, and eligibility details, while older wording was removed or superseded to align with the new structure.
    Difference
    3%
    Check dated 2026-05-30T23:26:35.000Z thumbnail image

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.